pimonidazole has been researched along with Chronic Kidney Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arias, SCA; Ávila, VF; Câmara, NOS; Fanelli, C; Faustino, VD; Foresto-Neto, O; Fujihara, CK; Malheiros, DMAC; Moreira, GCDS; Nascimento, TF; Rempel, LCT; Zatz, R | 1 |
Evans, RG; Ngo, JP; Ow, CPC; Sayakkarage, A; Ullah, MM | 1 |
2 other study(ies) available for pimonidazole and Chronic Kidney Diseases
Article | Year |
---|---|
Chronic exposure to hypoxia attenuates renal injury and innate immunity activation in the remnant kidney model.
Topics: Animals; Gene Expression Regulation; Hypoxia; Immunity, Innate; Kidney; Male; Nephrectomy; Nitroimidazoles; Organ Size; Oxygen; Radiation-Sensitizing Agents; Rats; Renal Insufficiency, Chronic | 2019 |
Detection of cellular hypoxia by pimonidazole adduct immunohistochemistry in kidney disease: methodological pitfalls and their solution.
Topics: Acute Kidney Injury; Animals; Antibodies, Monoclonal; Antibody Specificity; Artifacts; Cell Hypoxia; Disease Models, Animal; False Positive Reactions; Immunohistochemistry; Kidney; Nitroimidazoles; Polycystic Kidney Diseases; Predictive Value of Tests; Rats, Inbred Lew; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Reperfusion Injury; Reproducibility of Results | 2019 |